Initiating a Buy rating on Upstream Bio, a small-cap biotech trading at an enterprise value under $200M. Click here to read my latest analysis of UPB stock.

Apogee Therapeutics advances zumilokibart with a $1.3B Blackstone deal, eyes $82.97 value despite asset risks. Read why APGE ...

Blackstone is providing as much as $1.3 billion in financing to Apogee Therapeutics (NASDAQ:APGE), giving the biotech company fresh capit ...

Blackstone Inc. is providing as much as $1.3 billion in financing to Apogee Therapeutics Inc. to help the biotech company ...

Sponsored by Regeneron and Sanofi. It was a perfect day for a shark dive. The skies were blue and the water off Guadalupe Island was crystal clear. Shane, a software engineer by trade and adventurer ...

As of Monday, May 18, Regeneron Pharmaceuticals, Inc.’s REGN share price has dipped by 10.63%, which has investors ...

SINGAPORE: At the height of her eczema flare, Ms Chloe Ng struggled to hold a pen or carry a spoon as her fingers were covered in open wounds. For years, she cycled through treatments, including oral ...

Detailed price information for Regeneron Pharmaceuticals (REGN-Q) from The Globe and Mail including charting and trades.

Indication now includes CSU in ages 2–11 with inadequate control on H1 antihistamines, filling a long-standing pediatric biologic gap. Mechanistically, dupilumab blocks IL‑4 and IL‑13 receptor ...

Please provide your email address to receive an email when new articles are posted on . Approval of dupilumab was extended to include children aged 2 to 11 years with chronic spontaneous urticaria.